HOME >> BIOLOGY >> NEWS
Gene Therapy For Pain

NIH scientists are attacking chronic pain with a novel form of gene therapy that targets the spinal cord. Though still in the animal testing stage, this approach has overcome one of the major obstacles to gene therapy as a way to manipulate spinal cord function. Rather than injecting genes directly into a localized area of the spinal cord, the pain-relieving gene is introduced into the sheath of tissue that surrounds the cord. From that strategic location, the gene can pump out its product and bathe many nerves, thus extending the range of its pain-numbing effect. The investigators hope that this simplified approach can be used to generate a variety of products in the tissue surrounding nerves, including factors that could stimulate new nerve growth.

The study, carried out by scientists from the National Institute of Dental and Craniofacial Research (NIDCR) and the University of Pennsylvania, was reported in the May 1 issue of Human Gene Therapy.

"We are totally pumped up that this approach is working in an animal model," said Dr. Mike Iadarola, chief of NIDCR's Neuronal Gene Expression Unit. "The animal studies have shown us that genes are readily taken up by the connective tissue cells that surround the central nervous system. So, given the right gene, our approach has application to a broad range conditions, from pain control to spinal cord injury and disorders like multiple sclerosis and Parkinson's disease."

In the study, investigators used an adenovirus--similar to a cold virus-- to deliver the beta-endorphin gene to the rat spinal cord. The virus particles were injected into the spinal fluid, where they were readily taken up by the protective sheath of connective tissue, called the pia mater, which surrounds the cord. Within 24 hours the sheath cells began secreting beta-endorphin, one of the body's natural sedatives for alleviating pain.

"The incredible simplicity and relative noninvasiveness of this approach provides a new fram
'"/>

Contact: Wayne Little
wayne.little@nih.gov
301-496-4261
NIH/National Institute of Dental and Craniofacial Research
1-May-1999


Page: 1 2 3

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
7. Invitation To Cover: American Society Of Gene Therapy Meeting
8. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
9. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
10. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant
11. University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2019)... ... May 13, 2019 , ... BioMedGPS is excited ... special Pre-EWMA 2019 event at Gothenburg’s Universeum Aquarium. Guests will be treated to ... in Advanced Wound Care. , SmartTRAK’s Advanced Wound Care Experts will serve as ...
(Date:5/8/2019)... ... May 08, 2019 , ... MMS Holdings – an award-winning, ... by Medrio , the leading provider of eClinical technology for small to ... collaborating to position high-quality CRO services with Medrio’s fast and easy-to-use eClinical products, ...
(Date:5/2/2019)... ... April 30, 2019 , ... Philadelphia intellectual property law ... that Gunes Bender, Ph.D., a registered patent agent, has joined the firm as ... role, Bender provides technical support and scientific expertise in the pharmaceutical and biotechnical ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/8/2019)... ... April 08, 2019 , ... ... and collaboration solutions, announced today the launch of their app integration solution, CT ... of business and contact-orientated applications while using CT Cloud Voice and Skype for ...
(Date:4/4/2019)... ... 02, 2019 , ... Biomeme, Inc. , a leading ... field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ... Franklin, an English chemist and X-ray crystallographer who made significant contributions to the ...
(Date:3/27/2019)... ... 2019 , ... A leader in the field of Regenerative Veterinary Medicine, VetStem ... States and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy ... dog, cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego ...
Breaking Biology Technology:
Cached News: